Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. (SEHK:2289) from a group of shareholders for approximately HKD 250 million on January 17, 2023. The transaction is expected to close on February 10, 2023. Guotai Junan Capital Limited acted as financial advisor to Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. and Merdeka Corporate Finance Limited acted as fairness opinion provider and financial advisor to Charmacy Pharmaceutical Co., Ltd. Rodney Teoh of Stevenson Wong & Co acted as legal advisor for Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd.

Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. (SEHK:2289) from a group of shareholders on February 10, 2023.